Pfizer recalls Accupril 20mg tablets (NDC 0071-0532-23) due to N-nitrosoquinapril levels exceeding safe limits. This may pose health risks. Contact Pfizer for details.
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Pfizer is recalling Accupril 20mg tablets (NDC 0071-0532-23) because they contain N-nitrosoquinapril above acceptable limits. This could pose health risks to people taking the medication.
The tablets contain N-nitrosoquinapril at levels above what is safe. N-nitroso compounds can be harmful to health, potentially causing issues like liver damage or other health problems.
People with a prescription for Accupril 20mg tablets (NDC 0071-0532-23) from Pfizer. Those with a prescription for this specific product are most at risk.
Check your prescription label for Accupril 20mg tablets with NDC 0071-0532-23. The product was distributed by Parke-Davis Division of Pfizer Inc. and has specific expiration dates.
Review your prescription label for Accupril 20mg tablets with NDC 0071-0532-23.
The recall record states the product contains N-nitrosoquinapril above acceptable limits, which may pose health risks. However, the official notice does not specify if it is safe to take.
The recall record does not provide a remedy or specific instructions for what to do with the product.
Check your prescription label for Accupril 20mg tablets with NDC 0071-0532-23. The product was distributed by Parke-Davis Division of Pfizer Inc.
We’ve drafted a message you can send Pfizer to request your refund or repair — edit it as you like.
Subject: Recall D-0873-2022 — Pfizer Pfizer Hello, I own a Pfizer that is covered by recall D-0873-2022 from Pfizer. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
